Mark Lingen to Early Detection of Cancer
This is a "connection" page, showing publications Mark Lingen has written about Early Detection of Cancer.
Connection Strength
3.528
-
Living evidence-informed guideline on the early detection of oral squamous cell carcinoma and potentially malignant disorders: Light-based adjuncts to determine the need for biopsy, Version 2026 1.0. J Am Dent Assoc. 2026 Sep; 157(9):968-979.
Score: 0.655
-
Living evidence-informed guideline on the early detection of oral squamous cell carcinoma and potentially malignant disorders: Vital staining adjuncts to determine the need for biopsy, Version 2026 1.0. J Am Dent Assoc. 2026 Jun; 157(6):576-587.
Score: 0.648
-
Living evidence-informed guideline on the early detection of oral squamous cell carcinoma and potentially malignant disorders: Cytology adjuncts to determine the need for biopsy, Version 2026 1.0. J Am Dent Assoc. 2026 Mar; 157(3):224-234.
Score: 0.643
-
Screening for oral premalignancy and cancer: what platform and which biomarkers? Cancer Prev Res (Phila). 2010 Sep; 3(9):1056-9.
Score: 0.220
-
Light-based adjuncts to determine the need for biopsy for early detection of oral squamous cell carcinoma and potentially malignant disorders: An evidence summary of a living systematic review, Version 2026 1.0. J Am Dent Assoc. 2026 Sep; 157(9):980-992.
Score: 0.164
-
Vital staining adjuncts to determine the need for biopsy for early detection of oral squamous cell carcinoma and potentially malignant disorders: An evidence summary of a living systematic review, Version 2026 1.0. J Am Dent Assoc. 2026 Jun; 157(6):588-601.
Score: 0.162
-
Cytology adjuncts to determine the need for biopsy for early detection of oral squamous cell carcinoma and potentially malignant disorders: An evidence summary of a living systematic review, Version 2026 1.0. J Am Dent Assoc. 2026 Mar; 157(3):235-246.
Score: 0.161
-
Oral cancer risk stratification: A cross-sectional population-based screening study in Northeast India. Int J Cancer. 2026 Mar 15; 158(6):1517-1527.
Score: 0.156
-
Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2021 12 10; 12:CD010173.
Score: 0.120
-
Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. Br J Cancer. 2022 02; 126(3):361-370.
Score: 0.120
-
Society of Behavioral Medicine position statement: Society of Behavioral Medicine supports oral cancer early detection by all healthcare providers. Transl Behav Med. 2019 07 16; 9(4):819-822.
Score: 0.102
-
Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: Diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association. J Am Dent Assoc. 2017 11; 148(11):797-813.e52.
Score: 0.090
-
Screening for oral cancer-a perspective from the Global Oral Cancer Forum. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jun; 123(6):680-687.
Score: 0.083
-
Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2013 Nov 21; (11):CD010173.
Score: 0.069
-
Brush-based cytology screening in the tonsils and cervix: there is a difference! Cancer Prev Res (Phila). 2011 Sep; 4(9):1350-2.
Score: 0.059
-
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2021 07 20; 7:CD010276.
Score: 0.029
-
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2015 May 29; (5):CD010276.
Score: 0.019
-
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. Tex Dent J. 2012 May; 129(5):491-507.
Score: 0.015
-
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010 May; 141(5):509-20.
Score: 0.013